US Patent Issued to TEGA THERAPEUTICS on May 26 for "In vitro heparin and heparan sulfate compositions and methods of making and using" (California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,307, issued on May 26, was assigned to TEGA THERAPEUTICS INC. (San Diego).

"In vitro heparin and heparan sulfate compositions and methods of making and using" was invented by Charles Glass (San Diego), Bryan Thacker (San Diego) and Jeffrey Esko (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are cellular derived heparin and heparan sulfate compositions, methods of making and using, and cell lines for making and using."

The patent was filed on Dec. 15, 2017, under Application No. 16/470,164.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sec...